CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1101
Avg. Estimate-0.15-2.550-4.05
Low Estimate-0.15-2.550-4.05
High Estimate-0.15-2.550-4.05
Year Ago EPS-0.6-1.05N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate2.6M300k3.8MN/A
Low Estimate2.6M300k3.8MN/A
High Estimate2.6M300k3.8MN/A
Year Ago Sales588k107k847k3.8M
Sales Growth (year/est)342.20%180.40%348.60%N/A
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-1.2-0.9-1.270
EPS Actual-0.6-1.05-0.75-0.9
Difference0.6-0.150.52-0.9
Surprise %50.00%-16.70%40.90%N/A
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.15-2.550-4.05
7 Days Ago-0.15-2.55-0.3-4.05
30 Days Ago-0.15-2.55-0.3-4.05
60 Days Ago-0.01-0.17-0.3-0.27
90 Days Ago-0.01-0.17-0.3-0.55
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCANFIndustrySectorS&P 500
Current Qtr.75.00%N/AN/A0.01
Next Qtr.-142.90%N/AN/A0.03
Current YearN/AN/AN/A0.04
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A